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Connective tissue growth factor, which is induced by
transforming growth factor b, has been reported to
mediate the stimulatory actions of transforming
growth factor b on type I procollagen synthesis.
Connective tissue growth factor is expressed in ®bro-
tic disease such as scleroderma, where it is believed
to promote abnormal deposition of collagen.
Connective tissue growth factor expression has not
been described in normal human skin or cultured
skin cells, however. We report here that connective
tissue growth factor mRNA is constitutively
expressed in normal human skin. In situ hybridiza-
tion demonstrated that connective tissue growth fac-
tor mRNA was expressed in keratinocytes
throughout the epidermis and in dermal cells.
Quantitative real-time reverse transcription polymer-
ase chain reaction revealed that the level of connect-
ive tissue growth factor mRNA in the epidermis and
dermis of normal human skin was comparable to the
level of housekeeping gene 36B4. Ultraviolet irradi-
ation (2 minimal erythema dose, UVB/A2 source)
reduced connective tissue growth factor mRNA
expression throughout the epidermis and dermis in
normal human skin in vivo. Connective tissue growth
factor mRNA was reduced (30%) within 4 h post
ultraviolet irradiation, and remained reduced (50%)
8±24 h post ultraviolet. Connective tissue growth fac-
tor mRNA and protein were also constitutively
highly expressed in normal cultured human skin ker-
atinocytes and ®broblasts. Ultraviolet irradiation of
cultured normal human skin ®broblasts resulted in a
time-dependent inhibition of connective tissue
growth factor mRNA expression. At 24 h post ultra-
violet, connective tissue growth factor mRNA
expression was reduced 80%. Transforming growth
factor b1 rapidly induced connective tissue growth
factor mRNA levels (5-fold within 4 h) in skin ®bro-
blasts, but not keratinocytes, and this induction was
attenuated 80% by ultraviolet irradiation.
Electrophoretic mobility shift assays demonstrated
that ultraviolet irradiation reduced protein binding
to the transforming growth factor b/Smad respon-
siveness elements in the connective tissue growth
factor gene promoter, in human skin in vivo and
human skin ®broblasts. Constitutive expression of
connective tissue growth factor in normal human
skin suggests that it is a physiologic regulator of pro-
collagen synthesis. Ultraviolet reduction of connect-
ive tissue growth factor expression may contribute to
reduced procollagen synthesis observed in ultravio-
let-irradiated normal human skin and human skin
®broblasts. Key words: connective tissue growth factor/
TGF-b/ultraviolet irradiation. J Invest Dermatol 118:402±
408, 2002
C
onnective tissue growth factor (CTGF) is a member of
the CCN (CTGF/CYR61/NOV) family of novel
cysteine-rich, secreted proteins. It was ®rst identi®ed
in culture medium of human umbilical vein endothe-
lial cells (Bradham et al, 1991). CTGF stimulates
connective tissue cell proliferation, chemotaxis, and adhesion
(Grotendorst, 1997; Brigstock, 1999; Duncan et al, 1999; Gupta et
al, 2000). CTGF expression is rapidly induced by transforming
growth factor b (TGF-b) in skin ®broblasts and accumulating
evidence indicates that the inductive effects of TGF-b on
procollagen production are mediated by CTGF (Grotendorst,
1997; Brigstock, 1999; Duncan et al, 1999; Gupta et al, 2000).
CTGF stimulates procollagen production when injected into mouse
skin or added to ®broblast cultures (Duncan et al, 1999). It is
overexpressed in ®brotic conditions affecting the skin, lungs, and
kidneys and therefore is believed to be an important mediator of
®brosis. It has been reported that CTGF is not expressed in normal
human skin in vivo or in normal cultured human skin ®broblasts
(Igarashi et al, 1995; 1996). Therefore, the role of CTGF in
physiologic regulation of procollagen gene expression in normal
human skin and normal human skin ®broblasts has not been studied.
Inhibition of type I procollagen production in sun-exposed
human skin by solar ultraviolet (UV) irradiation is a major
contributing factor to sun-induced skin aging. TGF-b is the
major regulator of type I procollagen synthesis (Ignotz and
Massague, 1986; Varga et al, 1987; Chen et al, 1999), and it has
been demonstrated that UV irradiation impairs the TGF-b/Smad
pathway (Quan et al, 2001). As TGF-b is the primary regulator of
CTGF expression, we have investigated the expression of CTGF
and its regulation by UV in normal human skin in vivo and in
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normal human skin ®broblasts. We demonstrate that CTGF is
constitutively expressed in normal human skin in vivo and in normal
human skin keratinocytes and ®broblasts. We also demonstrate that
UV irradiation inhibits CTGF gene expression both in normal
human skin in vivo and in normal human skin ®broblasts. Our data
raise the possibility that CTGF is a physiologic mediator of TGF-b
regulation of type I procollagen synthesis in normal human skin,
and reduced CTGF gene expression by UV may contribute to the
known ability of UV to inhibit type I procollagen synthesis in
normal human skin in vivo.
METHODS AND MATERIALS
Materials Dulbecco's modi®ed Eagle's medium (DMEM), fetal
bovine serum, trypsin solution, penicillin, streptomycin, and L-glutamine
were purchased from Life Technology (Rockville, MD). Epilife
keratinocyte culture medium was purchased from Cascade Biologics
(Portland, OR). CTGF antibody for Western analysis and human
recombinant TGF-b1 was purchased from R&D Systems (Minneapolis,
MN). [g-32P]ATP and [a-32P]dCTP were obtained from Perkin Elmer
Life Sciences (Boston, MA). All other reagents were purchased from
Sigma Chemical Company (St. Louis, MO).
Procurement of human tissue samples and UV irradiation Human
skin samples were obtained from adult volunteers, as previously described
(Fisher et al, 1991a, 1997, 1998). Sun-protected buttock skin of human
volunteers was irradiated with 2 minimal erythema dose (MED) UV
using an Ultralite Panelite lamp containing four FS36T12 UVB-HO
bulbs (47% UVB, 18% UVA2, 9% UVA1, 26% visible light).
Wavelengths below 290 nm (UVC) were removed by a Kodacel
TA401/407 sheet (Eastman Kodak, Rochester, NY). The UV dose that
caused barely perceptible skin reddening (MED) was determined for each
subject, 24 h after irradiation. All procedures involving human subjects
were approved by the University of Michigan Institutional Review
Board, and all subjects provided written informed consent.
Cell culture and UV irradiation Human buttock skin ®broblasts and
keratinocytes were cultured from keratome biopsies of adult normal
buttock skin. Dermis was separated from epidermis by trypsinization of
the tissue and keratinocytes were cultured from the resulting epidermal
cell suspension, in complete modi®ed MCDB153 (Epilife). The dermis
was cut into small pieces and placed in culture for 1 wk in DMEM
supplemented with 10% fetal bovine serum, penicillin (100 U per ml),
and streptomycin (100 mg per ml), in a humidi®ed incubator with 5%
CO2 at 37°C. Dermal fragments were then removed and ®broblast
cultures were expanded by passage as described previously (Fisher et al,
1991b). Cells were utilized between passages 3 and 6. For UV
irradiation, subcon¯uent cells were irradiated with UV (30 mJ per cm2)
using a Daavlin lamp containing six FS24T12 UVB-HO bulbs. A
Kodacel ®lter was used to eliminate wavelengths below 290 nm (UVC).
The irradiation intensity was monitored with an IL1400A phototherapy
radiometer and an SED240/UVB/W photodetector (International Light,
Newbury, MA). Following irradiation, the original media were put back
into the same plates. For TGF-b1 treatment, cells were incubated for 8 h
following exposure to UV. TGF-b1 (5 ng per ml) was added to media
and cells were again incubated for 4 h.
RNA isolation and northern blot analysis Total RNA from normal
human skin and cultured normal human skin ®broblasts was extracted
with a commercial kit (RNeasy Midi Kit, Qiagen, Chatsworth, CA)
according to the manufacturer's protocol. Samples of total RNA (30 mg)
were resolved by 1.2% agarose electrophoresis, transferred to nylon
membranes, and hybridized with CTGF or 36B4 cDNA probes labeled
with [a-32P]dCTP by random priming. cDNA probes for CTGF were
generously provided by Dr. Grotendorst (Department of Cell Biology
and Anatomy, University of Miami School of Medicine, Miami, FL).
Each blot was stripped and re-hybridized with 36B4 internal control
gene transcript to monitor the sample load in each lane. The intensities
of each band were visualized and quanti®ed by STORM
PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
Laser capture microdissection Full-thickness human skin samples
were embedded in OCT, sectioned, and stained with hematoxylin.
Approximately 200 ®broblasts identi®ed by histology and
immunohistology (positive for type I (a1) procollagen and vimentin, and
negative for CD45), were captured using laser capture microdissection
(Holland et al, 1993; Livak et al, 1995; Fend et al, 1999; Jin et al, 1999;
Figure 1. CTGF mRNA is expressed in epidermis and dermis of normal human skin in vivo. (A) Total RNA was prepared from buttock skin
samples from healthy adult subjects (subj) and CTGF and 36B4 mRNA expression was determined by northern analysis. (B) CTGF mRNA was
localized in normal human skin by antisense riboprobe in situ hybridization (left panel). The sense riboprobe yielded minimal background signal (right
panel). Results are representative of 10 individuals. (C) Full-thickness normal human skin samples were physically separated by dissection into epidermis
and dermis. CTGF and 36B4 mRNA levels were quanti®ed in the epidermis and dermis by real-time RT-PCR. Results are expressed as mean 6
SEM of CTGF and 36B4 mRNA molecules per 10 ng total RNA. N = 4. (D) Fibroblasts in the upper dermis of normal human skin were obtained
from frozen sections by laser capture microdissection. Total RNA was prepared, and CTGF and 36B4 mRNA were quanti®ed by real-time RT-PCR.
Results are expressed as mean 6 SEM of CTGF and 36B4 mRNA molecules per 10 ng total RNA. N = 6.
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Luo et al, 1999). Total RNA was extracted using a commercial kit
(Micro RNA Isolation Kit, Stratagene, La Jolla, CA).
Quantitative real-time reverse transcription polymerase chain
reaction (RT-PCR) Total RNA 100 ng was reverse transcribed,
with random primers, using Taqman Reverse Transcription kit (Applied
Biosystems, Foster City, CA). One-tenth of the reverse transcription
reaction was utilized for real-time PCR. Real-time PCR was performed
on a 7700 Sequence Detector (Applied Biosystems) using one-tenth of
the reverse transcription reaction and Taqman Universal PCR Master
Mix Reagents (Applied Biosystems). PCR primers and probes were
produced by the custom oligonucleotide synthesis service (Applied
Biosystems). Primers and FAM labeled probe for CTGF real-time PCR
are as follows: sense primer, 5¢-GTTTGGCCCAGACCCAACT-3¢;
antisense primer, 5¢-GGAACAGGCGCTCCACTCT-3¢; probe, TGA-
TTAGAGCCAACTGCCTGGTCCA. Primers and VIC labeled probe
for 36B4 are as follows: sense primer, 5¢-ATGCAGCAGATCC-
GCATGT-3¢; antisense primer, 5¢-TTGCGCATCATGGTGTTCTT-3¢;
probe, 5¢-CGCGGGAAGGCTGTGGTGCT-3¢. Multiplex PCRs
contained primers and probes for CTGF and 36B4. CTGF and 36B4
mRNA levels were quanti®ed based on standard curves. For comparison
among treatment groups, CTGF levels were normalized to 36B4 levels.
In situ hybridization Plasmid DNA containing CTGF cDNA was
linearized with ApaI and HindIII for sense and antisense probes,
respectively. Digoxigenin-containing sense and antisense riboprobes for
detecting human CTGF was synthesized using T7 and SP6 ribonucleic
polymerase, respectively. Frozen skin sections (5 mm) were mounted,
®xed, treated, and hybridized as previously described (Fisher et al, 1997).
Hybridization signals were detected immunohistochemically by alkaline-
phosphatase-conjugated antidigoxigenin antibody.
Western analysis Human keratinocytes and ®broblasts were cultured
in serum-free basal media for 24 h. Conditioned media (0.5 ml) were
collected and concentrated, and the protein content was measured by
Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA) using
bovine serum albumin as a standard. Proteins in the concentrated media
(50 mg) were resolved on 14% sodium dodecyl sulfate polyacrylamide gel
and blotted as previously described (Quan et al, 2001). CTGF antibody
(R&D Systems, Minneapolis, MN) was used at a dilution of 1:500. Blots
were developed with ECF (Vistra ECF Western Blotting System,
Amersham-Pharmacia Biotech, Piscataway, NJ) following the
manufacturer's protocol. Intensities of each band were visualized by
STORM PhosphorImager (Molecular Dynamics).
Electrophoretic mobility shift assay (EMSA) EMSAs were
performed using whole cell extracts from human skin samples and
nuclear extracts from cultured skin ®broblasts. Double-stranded
oligodeoxynucleotides containing the TGF-b response element and
Smad binding element (Grotendorst et al, 1996; Holmes et al, 2001) in
the CTGF gene promoter (5¢-CAGCTTTTTCAGACGGAGGAAT-
GCTGAGTGTCAAGGGGTCAGGATCAA-3¢ and its complementary
strand) were used as probes. EMSAs were performed as described
previously (Quan and Fisher, 1999). For competition experiments, a 10±
50-fold molar excess of unlabeled probe was preincubated with nuclear
extract for 30 min on ice before labeled probe was added. Gels were
transferred to 3MM Whatman paper, vacuum-dried, and visualized and
quanti®ed by STORM PhosphorImager (Molecular Dynamics).
Transient transfection and luciferase assays Plasmid DNA (1 mg)
containing the b-galactosidase gene (pCMVb, Clontech Laboratories,
Palo Alto, CA) to provide an internal standard for transfection ef®ciency
was transiently cotransfected with TGF-b/luciferase reporter gene (Zawel
et al, 1998) (SBEX4, containing four repetitions of the GTCTAGAC
Smad 3/4 binding motif, provided by Dr. Bert Vogelstein of the Johns
Hopkins Oncology Center, Baltimore, MD). Plasmids were introduced
into normal human keratinocytes using Fugen 6 (Roche Molecular,
Indianapolis, IN) according to the manufacturer's protocol. After 24 h of
transfection, cells were treated with TGF-b1 (5 ng per ml). Forty-four
hours after transfection, cells were washed once with phosphate-buffered
saline (PBS), harvested in lysis buffer (BD PharMingen, San Diego, CA),
and assayed for b-galactosidase activity. Luciferase activity was measured
using an enhanced luciferase assay kit (BD PharMingen) according to the
manufacturer's protocol. Aliquots containing identical b-galactosidase
activity were used for each luciferase assay.
Figure 2. UV irradiation inhibits CTGF mRNA expression in
normal human skin in vivo. (A) Normal buttock human skin was
irradiated with 2 MED UV. Skin samples were obtained 16 h post UV,
and CTGF mRNA expression was determined by antisense riboprobe in
situ hybridization. Sense riboprobe yielded minimal background signal.
Results are representative of six subjects. (B) Normal buttock human
skin was irradiated with 2 MED UV. Skin samples were obtained at
indicated times post UV, and total RNA was extracted. CTGF and
36B4 mRNA levels were quanti®ed by real-time RT-PCR. CTGF
mRNA levels were normalized to 36B4 mRNA levels. Results are
expressed as mean 6 SEM, N = 9, *p < 0.05.
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Statistical analysis Comparisons among treatment groups were made
with the paired t test (two groups) or the repeated measures ANOVA
(more than two groups). Multiple pairwise comparisons were made with
the Tukey Studentized range test. All p-values are two-tailed, and
considered signi®cant when < 0.05.
RESULTS
CTGF mRNA is expressed in normal human skin
in vivo Northern analysis for CTGF mRNA using total RNA
(30 mg per lane) from skin samples from three normal human
subjects revealed a band of 2.4 kb, the expected transcript size for
CTGF mRNA (Fig 1A). To verify that human skin expresses
CTGF mRNA, total RNA was reverse transcribed and the
resulting cDNA was used as a template for PCR with speci®c
CTGF primers. PCR yielded a single major product of the
expected size (1.2 kb) (data not shown). This PCR product was
cloned and sequenced. The sequence was identical to human
CTGF.
In situ hybridization of normal human skin with antisense CTGF
riboprobe demonstrated that CTGF mRNA is highly expressed
throughout the epidermis and dermal cells (Fig 1B). Sense CTGF
riboprobe showed minimal background signal. These data dem-
onstrate that CTGF gene is expressed in normal human skin.
Snap-frozen, full-thickness human skin samples were dissected to
separate epidermis from dermis, and CTGF transcripts were
quanti®ed by real-time RT-PCR. The level of CTGF mRNA
in the epidermis (3.7 3 106 copies per 10 ng total RNA) of normal
human skin was comparable to that of housekeeping gene 36B4
(Fig 1C). The level of CTGF mRNA in the dermis (9.5 3 106
copies per 10 ng total RNA) was 2-fold higher than 36B4. To
monitor separation of epidermis from dermis levels of keratin 14
mRNA, a marker of basal keratinocytes, and type I procollagen
mRNA, a marker of dermal ®broblasts, were determined in each
fraction. Type I procollagen mRNA levels were reduced 100-fold
in the epidermis relative to dermis indicating that dermal contam-
ination of the epidermis was minimal. Keratin 14 mRNA levels,
however, in the dermal fraction were reduced only 5-fold relative
to the epidermis, indicating keratinocyte contamination in the
dermal fraction, most probably from deeper appendages such as hair
follicles and sweat glands. We therefore utilized laser capture
microdissection to obtain dermis free of contaminating epidermis.
The level of CTGF mRNA in the pure dermal fraction, composed
primarily of ®broblasts from upper dermis, was ®ve times the level
of 36B4 mRNA (Fig 1D).
Previous studies have demonstrated CTGF gene expression in
scleroderma lesional skin, but failed to detect CTGF expression in
nonlesional skin and normal skin, using in situ hybridization of
paraf®n-embedded sections (Igarashi et al, 1995, 1996). As we
could readily detect CTGF mRNA in normal human skin, we
determined the relative levels of CTGF mRNA in full-thickness
lesional and nonlesional scleroderma skin from two subjects, by
real-time RT-PCR. CTGF mRNA was increased 2.1-fold in one
subject and 3.9-fold in another subject, compared to matched
nonlesional skin (data not shown).
UV irradiation inhibits CTGF mRNA expression in normal
human skin in vivo. As CTGF is induced by TGF-b and UV
irradiation impairs TGF-b signaling, we speculated that UV
irradiation might reduce CTGF expression. To test this possibility,
normal human skin was UV irradiated and then CTGF mRNA
expression was determined by in situ hybridization and real-time
RT-PCR. CTGF mRNA expression was substantially reduced
throughout epidermis and dermis at 16 h post UV as determined by
antisense riboprobe in situ hybridization (Fig 2A). Real-time RT-
PCR revealed that CTGF mRNA was signi®cantly reduced within
8 h (50%) following UV irradiation, and remained decreased for at
least 24 h post UV, in normal human skin in vivo (Fig 2B).
CTGF is expressed in normal human skin keratinocytes and
®broblasts The above data demonstrate that keratinocytes and
®broblasts in normal human skin express CTGF mRNA. We next
examined expression of CTGF mRNA and protein in cultured
normal human skin keratinocytes and ®broblasts. CTGF mRNA
and protein were highly expressed and readily detectable in both
normal human skin keratinocytes and ®broblasts (Fig 3A, B). The
Figure 3. CTGF mRNA and protein are expressed in normal
human skin ®broblasts and keratinocytes. (A) Total RNA was
isolated from normal cultured human skin ®broblasts and keratinocytes.
CTGF and 36B4 mRNA levels were determined by real-time RT-
PCR, respectively. Results are expressed as mean 6 SEM of CTGF and
36B4 mRNA molecules per 10 ng total RNA. N = 3. (B) Conditioned
media was collected from cultured normal human skin ®broblasts and
keratinocytes. CTGF protein was determined by Western analysis. N = 3.
Figure 4. TGF-b1 induces CTGF mRNA in normal human skin
®broblasts, but not keratinocytes. Normal human skin ®broblasts and
keratinocytes were treated with TGF-b1 (5 ng per ml). Cells were
harvested at indicated time points and total RNA was extracted. CTGF
and 36B4 mRNA levels were quanti®ed by real-time RT-PCR. CTGF
mRNA levels were normalized to 36B4 mRNA levels. Data are
expressed as mean 6 SEM, N = 3, *p < 0.05 vs control.
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level of CTGF mRNA in keratinocytes was 2-fold higher than that
of the housekeeping gene 36B4, whereas CTGF mRNA in
®broblasts was 3-fold higher than 36B4 (Fig 3A). Western analysis
revealed that both keratinocytes and ®broblasts secreted CTGF
protein with a molecular weight of 38,000 (Fig 3B).
TGF-b rapidly induced CTGF mRNA in human skin
®broblasts. CTGF mRNA was elevated 5-fold within 4 h of
TGF-b treatment, and 10-fold at 24 h post treatment (Fig 4). In
contrast, TGF-b treatment did not signi®cantly induce CTGF
mRNA in cultured keratinocytes. This was not due to failure of
keratinocytes to activate the TGF-b/Smad pathway, as a TGF-b/
Smad-dependent reporter gene (containing SBEX4 four copies of
the Smad 3/4 binding element) was induced 3-fold by TGF-b in
cultured keratinocytes (data not shown).
UV irradiation inhibits CTGF mRNA expression in normal
human skin ®broblasts As UV irradiation inhibits CTGF
expression in human skin in vivo (Fig 2), we next examined the
effect of UV irradiation on CTGF mRNA expression in cultured
normal human skin ®broblasts. UV irradiation reduced CTGF
mRNA levels 25% within 4 h, and 80% at 24 h post UV (Fig 5A).
We have previously demonstrated that UV impairs TGF-b/
Smad signaling by downregulating the type II TGF-b receptor
(Quan et al, 2001). This impairment in TGF-b signaling would be
expected to inhibit TGF-b-induced CTGF expression. We next
examined whether UV irradiation inhibits TGF-b-induced CTGF
mRNA expression in normal human skin ®broblasts. As expected,
TGF-b1 treatment alone resulted in a substantial increase in CTGF
mRNA levels (Fig 5B). Pretreatment of ®broblasts with UV
irradiation 8 h prior to addition of TGF-b1 reduced TGF-b-
induced CTGF mRNA by 90% (Fig 5B). These data demonstrate
that UV irradiation inhibits CTGF gene expression, and pretreat-
ment of normal human skin ®broblasts with UV blocks TGF-b1-
induced CTGF mRNA.
UV irradiation reduces protein±DNA complex formation
on CTGF promoter The human CTGF gene promoter
contains a Smad 3/4 binding element and an adjacent upstream
unique TGF-b responsive element that are required for CTGF
gene expression (Grotendorst et al, 1996; Holmes et al, 2001). We
examined whether UV reduction of CTGF mRNA expression is
associated with reduced binding of transcription factors to this
critical region of the CTGF gene promoter. EMSA of normal
human skin and cultured skin ®broblasts revealed a single major
speci®c retarded complex that was competed for by excess
unlabeled probe (Fig 6). UV irradiation resulted in substantial
reduction of the retarded complexes in both normal human skin
(Fig 6A) and cultured human ®broblasts (Fig 6B). Reduced
transcription factor binding was observed within 4 h after UV
irradiation, consistent with the observed time course for UV
reduction of CTGF mRNA (Figs 2, 5).
DISCUSSION
The above data demonstrate that CTGF is constitutively expressed
in normal human skin in vivo throughout the epidermis and dermis,
and also in normal cultured human skin keratinocytes and
®broblasts. Real-time RT-PCR indicates that the level of CTGF
mRNA in the epidermis and cultured keratinocytes is similar to the
level of a highly expressed mRNA for ribosomal protein 36B4.
CTGF mRNA levels in the dermis of normal human skin and
cultured skin ®broblasts are 2±3-fold higher than those of 36B4.
To date, TGF-b is the most potent inducer of CTGF gene
expression. CTGF, like TGF-b, stimulates type I procollagen
production when injected into mouse skin or added to ®broblast
cultures (Duncan et al, 1999). Accumulating evidence indicates that
the inductive effects of TGF-b on type I procollagen production
are mediated by CTGF (Grotendorst, 1997; Brigstock, 1999;
Duncan et al, 1999; Gupta et al, 2000). TGF-b-induced type I
procollagen production can be inhibited by either neutralization of
CTGF using anti-CTGF antibodies or blocking of CTGF expres-
sion using an antisense expression construct (Grotendorst, 1997;
Duncan et al, 1999). These previous results together with our
®nding that CTGF is expressed in normal human skin suggest that
CTGF is an intrinsic, physiologic mediator of TGF-b regulation of
type I procollagen synthesis in normal human skin.
Interestingly, in situ hybridization and real-time RT-PCR
demonstrated that CTGF is highly expressed in epidermal
keratinocytes in normal human skin in vivo. The functional role
of CTGF in normal human epidermis remains to be elucidated.
Although the pro®brotic activity of CTGF has received consider-
able attention, CTGF also plays an essential role in cellular
differentiation and development (Surveyor et al, 1998).
Additionally, CTGF stimulates cell proliferation, chemotaxis, and
adhesion (Grotendorst, 1997; Brigstock, 1999; Duncan et al, 1999;
Gupta et al, 2000). CTGF expression in keratinocytes, unlike skin
Figure 5. UV irradiation inhibits CTGF mRNA expression in
normal human skin ®broblasts. (A) Normal human skin ®broblasts
were irradiated with UV (UVB/A2 source, 30 mJ per cm2). Cells were
harvested at indicated time points and total RNA was isolated. CTGF
and 36B4 mRNA levels were quanti®ed by real-time RT-PCR. CTGF
mRNA levels were normalized to 36B4 mRNA levels. Data are
expressed as mean 6 SEM, N = 3, *p < 0.05. (B)UV irradiation inhibits
TGF-b1-induced CTGF mRNA expression in normal human skin
®broblasts. Normal human skin ®broblasts were irradiated with UV
(UVB source, 30 mJ per cm2) for 8 h prior to addition of TGF-b1 (5 ng
per ml). Cells were harvested 4 h after TGF-b1 treatment and analyzed
by real-time RT-PCR. CTGF mRNA levels were normalized to 36B4
mRNA levels. Data are expressed as mean 6 SEM, N = 3, *p < 0.05 vs
TGF-b1 treated.
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®broblasts, was not induced by TGF-b. CTGF is also not regulated
by TGF-b in human hepatic cells (Frazier et al, 1996; Lasky et al,
1998), breast epithelial cells (Grotendorst et al, 1996), and
lymphocytes (Grotendorst, 1997; Abraham et al, 2000). Thus, the
pathways that regulate expression of CTGF and the biologic
functions of CTGF appear to be cell-type dependent. Identi®cation
of signaling pathways that mediate the actions of CTGF will better
de®ne the role of CTGF in different cell types.
Previous reports failed to detect CTGF mRNA by in situ
hybridization in normal human skin or skin ®broblasts. These
studies, however, did detect CTGF transcripts in ®brotic skin
lesions of scleroderma patients and cultured scleroderma ®broblasts.
We found that CTGF mRNA levels are 2±4-fold greater in lesional
scleroderma skin than in nonlesional skin. It is possible that lower
CTGF mRNA levels in normal human skin may have contributed
to their lack of detection in earlier studies. Reduced sensitivity of in
situ hybridization with paraf®n-embedded sections, utilized in
previous studies, compared to frozen sections, utilized in this study,
may also have contributed to the previous inability to detect CTGF
mRNA in normal human skin.
We have previously shown that a single exposure to UV
irradiation causes substantial loss of type I procollagen expression in
normal human skin in vivo (Fisher et al, 2000). UV inhibition of
type I procollagen production in normal human skin is one of the
major contributing factors to UV-induced photoaging (Fisher and
Voorhees, 1998). Here we demonstrate that UV irradiation inhibits
CTGF gene expression both in normal human skin in vivo and in
normal human skin ®broblasts. These data raise the possibility that
reduced CTGF expression might mediate, in part, UV inhibition of
type I procollagen expression in normal human skin.
The mechanisms of UV inhibition of CTGF gene expression
remain unknown. One likely mechanism may involve UV
impairment of the TGF-b/Smad pathway, as TGF-b is a major
regulator of CTGF gene expression. We have previously reported
that UV irradiation downregulates type II TGF-b receptor and
thereby substantially reduces cellular responsiveness to TGF-b
(Quan et al, 2001). Deletion analysis and gel mobility shift assay
identi®ed a 13 bp sequence (± 157/±145, GTGTCAAGGGGTC)
within the proximal region of the CTGF promoter as a TGF-b
response element (Grotendorst et al, 1996). In addition, recently
Holmes et al (2001) reported that the CTGF gene is directly
regulated by the TGF-b/Smad pathway through a Smad 3/4
binding element (±173/±166) located 9 bp downstream of the
previously identi®ed TGF-b response element. We found that UV
irradiation of human skin in vivo and cultured skin ®broblasts
reduced binding of transcription factors to the TGF-b/Smad
responsive elements. These data support the possibility that UV-
induced impairment of the TGF-b/Smad pathway contributes to
UV inhibition of CTGF gene expression.
Additionally, UV irradiation induces c-Jun, a major component
of the transcription factor AP-1, in keratinocytes and ®broblasts in
normal human skin in vivo (Fisher et al, 2000). c-Jun directly
interacts with activated Smad proteins in the nucleus to prevent
their binding to target genes (Verrecchia et al, 2000). c-Jun also
competes with Smad proteins for the common transcription
coactivator p300. Both mechanisms can simultaneously contribute
to the c-Jun inhibition of the TGF-b/Smad signaling pathway by
c-Jun. Therefore, interference with the TGF-b/Smad signaling
pathway by UV-induced c-Jun may also contribute to UV
inhibition of CTGF gene expression.
Abraham et al (2000) reported that tumor necrosis factor a
(TNF-a) inhibits TGF-b-induced CTGF gene expression in
foreskin ®broblasts. This suppression of CTGF is mediated by
the NFkB pathway. UV irradiation activates NFkB and induces
TNF-a in normal human skin in vivo (Barr et al, 1999; Brink et
al, 2000). Therefore, activation of NFkB and/or induction of
TNF-a may also contribute to inhibition of CTGF expression
by UV.
Figure 6. UV irradiation inhibits protein±DNA complex formation on the CTGF promoter. (A) Normal buttock human skin was irradiated
with 2 MED UV, and skin samples were obtained at indicated times post UV. Whole cell protein extracts were analyzed by EMSA using a 48 bp
fragment from the human CTGF promoter that contains the TGF-b response element and Smad 3/4 binding element as a probe. Closed triangle
indicates speci®c retarded complexes. Open triangle indicates nonspeci®c bands. Intensity of shifted complexes were quanti®ed by STORM
PhosphorImager. N = 3. *p < 0.05 (B)Normal human skin ®broblasts were irradiated with UV (UVB/A2 source, 30 mJ per cm2), and cells were
harvested at indicated times post UV. Nuclear extracts were prepared and analyzed by EMSA as described above (A). Closed triangle indicates speci®c
retarded complexes. Open triangle indicates nonspeci®c bands. Intensity of shifted complexes was quanti®ed by STORM PhosphorImager. N = 3. *p
< 0.05.
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In summary, CTGF is constitutively expressed in normal human
skin in vivo and in normal human skin keratinocytes and ®broblasts.
UV irradiation inhibits CTGF gene expression both in normal
human skin in vivo and in normal human skin ®broblasts. This
inhibition may contribute to UV reduction of type I procollagen
synthesis in normal human skin in vivo.
We are indebted to Carolyn Petersen and Suzan Rehbine for the procurement of
tissue specimens, JingCheng Wang, YueXian Hu, and Yu-Chen Hu for technical
assistance, Laura VanGoor for the preparation of graphic material, Ted Hamilton for
statistical analysis, and Anne Chapple for editorial assistance.
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